{"id":"2e7185dc2f8e","type":"article","url":"https://hartvaat.nl/2025/01/01/sirolimus-eluerende-bioresorbeerbare-stents-versus-everolimus-eluerende-stents-i/","title":"Sirolimus-eluerende bioresorbeerbare stents versus everolimus-eluerende stents (IRONMAN II)","title_en":"Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention: A Randomized Trial (IRONMAN II)","category":"algemeen","category_label":"Algemeen","professions":["cardioloog"],"tags":[],"journal":"JACC","doi":"https://www.sciencedirect.com/science/article/pii/S0735109725104920?dgcid=rss_sd_all","source_url":"https://doi.org/https://www.sciencedirect.com/science/article/pii/S0735109725104920?dgcid=rss_sd_all","authors":["Runlin Gao","Lei Song","Guosheng Fu","Changdong Guan","Yang Li","Shaobin Jia","Yong He","Jiyan Chen","Feng Qi","Mengyue Yu"],"significance":7,"published":"2026-03-01","source_date":"2025-01-01","image":"","kennis":["https://hartvaat.nl/kennis/coronairlijden/pci-percutane-coronaire-interventie/"],"congress":"","summary_en":"This randomized trial compared sirolimus-eluting iron bioresorbable scaffolds with everolimus-eluting permanent stents for PCI, evaluating the next generation of bioresorbable technology after the setbacks with earlier polymer-based scaffolds.","created":"2026-07-03T10:25:45Z","updated":"2026-07-03T13:25:08Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Gerandomiseerde trial die sirolimus-eluerende ijzer-bioresorbeerbare stents vergelijkt met everolimus-eluerende stents voor percutane coronaire interventie.","abstract_original":"Publication date: 28 April 2026Source: JACC, Volume 87, Issue 16"}